Combined taurine, epigallocatechin gallate and genistein therapy reduces HSC-T6 cell proliferation and modulates the expression of fibrogenic factors.

Combined taurine, epigallocatechin gallate and genistein therapy reduces HSC-T6 cell proliferation and modulates the expression of fibrogenic factors.
复制标题

牛磺酸、表没食子儿茶素没食子酸酯和金雀异黄素联合治疗可减少 HSC-T6 细胞增殖并调节纤维形成因子的表达。

DOI:
10.3390/ijms141020543
复制
发表时间:
2013-10-14
影响因子:
5.6
通讯作者:
Liao M
Liao M
中科院分区:
生物学2区
文献类型:
--
作者:
Li Y;Luo Y;Zhang X;Lin X;He M;Liao M

文献摘要

参考文献

被引文献

相似文献

Hepatic fibrogenesis involves the activation of hepatic stellate cells (HSCs), which synthesize excess extracellular matrix and contribute to the development of liver fibrosis. In a prior study we tested the effect of combined treatment with taurine, epigallocatechin gallate and genistein on the development of alcohol-induced liver fibrosis in vitro. In this study, the biological activity of the combination of these molecules was assessed by measuring its effect on cell proliferation, fibrosis-related gene expression, and proteomic expression profiling in the activated HSC cell line, HSC-T6. HSC-T6 cells were incubated with different concentrations of the drug combination taurine, epigallocatechin gallate and genistein. Cell proliferation was evaluated by MTT assay. Transforming growth factor β1 (TGF-β1), collagen type I (Col-I), matrix metalloproteinase-2 (MMP-2), and tissue inhibitor of metalloproteinases 1 and 2 (TIMP-1 and TIMP-2) mRNA were analyzed by semi-quantitative reverse-transcription PCR. Proteomic profiling of HSC-T6 cells was also performed by SELDI-TOF-MS. Combined drug treatment significantly inhibited cell proliferation and TGF-β1, Col-I, TIMP-1 and TIMP-2 mRNA expression in activated HSC-T6 cells, while the expression of MMP-2 mRNA increased. A total of 176 protein m/z peaks were identified. The intensities of 10 protein peaks were downregulated and two protein peaks were upregulated in HSC-T6 cells after combined drug treatment. In conclusion, combined drug treatment with taurine, epigallocatechin gallate and genistein can inhibit HSC proliferation, and impact fibrosis-related gene and protein expression. The antifibrotic effects of this drug combination may be due to its effects on the expression of fibrogenic genes.
DOI: 10.1038/sj.bjp.0705365
发表时间: 2003-08-01
影响因子: 7.3
作者:
Madhani, M;Scotland, RS;Hobbs, AJ
通讯作者: Hobbs, AJ
DOI: 10.1016/j.bpg.2011.02.005
发表时间: 2011-04
影响因子: 3.2
作者:
Lee, Ursula E.;Friedman, Scott L.
通讯作者: Friedman, Scott L.
DOI: 10.1016/j.jhep.2005.01.033
发表时间: 2005-07-01
影响因子: 25.7
作者:
Miyazaki, T;Karube, M;Bouscarel, B
通讯作者: Bouscarel, B
DOI: 10.1016/s0303-7207(02)00360-x
发表时间: 2003-01-31
影响因子: 4.1
作者:
Al-Gubory, KH;Huet, JC;Locatelli, A
通讯作者: Locatelli, A
DOI: 10.1016/j.hepres.2004.04.006
发表时间: 2004-09-01
影响因子: 4.2
作者:
Kato, J;Ido, A;Tsubouchi, H
通讯作者: Tsubouchi, H